Teva Pharmaceutical Industries Limited (TEVA)


NYSE - NYSE Real Time Price. Currency in USD
51.55+0.35 (+0.68%)
At close: 4:02 PM EDT
People also watch:
MYLNVSAMGNGILDABT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open51.35
Prev Close51.20
Bid51.48 x 100
Ask51.67 x 100
Day's Range51.14 - 51.98
52wk Range48.01 - 66.55
1y Target EstN/A
Market Cap47.12B
P/E Ratio (ttm)34.44
Beta0.51
Volume5,303,525
Avg Vol (3m)5,776,958
Dividend & Yield1.36 (2.64%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • The Wall Street Journal1 hour ago

    [$$] Overheard: Mylan May Play Hero

    Mylan, which is under fire for raising prices on its EpiPen allergy treatment, won a patent victory against rival Teva over the multiple sclerosis treatment Copaxone. The result: Mylan can potentially ...

  • The Wall Street Journal4 hours ago

    [$$] Overheard

    The pharma villain of the moment also has a project that could lower the cost of an important drug.

  • Billionaire John Paulson’s Favorite Healthcare Stocks Include The Latest Industry Punching Bag, Mylan
    Insider Monkey2 days ago

    Billionaire John Paulson’s Favorite Healthcare Stocks Include The Latest Industry Punching Bag, Mylan

    John Paulson is an American hedge fund manager and billionaire who founded his investment firm Paulson & Co in 1994 with only $2 million and one employee. By 2003, the fund’s assets had grown to $300 million. In 2006, Mr. Paulson started the famous ‘Credit Opportunities Fund’, which mainly bet against subprime mortgages. John Paulson […]